HIGHLIGHTS
- who: August and collaborators from the University of Ferrara, Italy have published the article: Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity, in the Journal: (JOURNAL) of 31/03/2021
SUMMARY
While usually helpful, brain MRI (Stosic et_al, 2010; Akasbi et_al, 2012; Magro Checa et_al, 2013; Magro-Checa et_al, 2018) and cerebrospinal fluid (CSF) analysis (Govoni et_al, 2016; Venhoff et_al, 2019) cannot consistently differentiate between MS and CNS involvement in the setting of SADs. Low-titer antinuclear (ANA) and antiphospholipid antibodies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.